Press Release

Recombinant Proteins Market: AMS Biotechnology Launches Recombinant Proteins and Antibodies to Detect COVID-19 Virus

The global recombinant proteins market size is estimated to flourish owing to the increasing research and development activities for developing advanced drugs to treat chronic diseases, observes Fortune Business Insights™ in an upcoming report, titled, “Recombinant Proteins Market Size, Share & Industry Analysis, By Type (Hormones, Growth Factors, Antibody, Enzyme, Others), By Application (Therapeutic, Research), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Others) and Regional Forecast 2020-2027.” The demand for protein production systems is increasing rapidly amid the COVID-19 pandemic owing to its utilization in the testing process.

Request a Sample Copy of the Research Report:

The emergence of COVID-19 has brought the world to a standstill. The crisis has brought an unprecedented impact on Industries across the globe. While some industries are thriving in the current scenario, some are struggling to even run their operations. Stimulus packages from governments and support from several companies are being utilized to overcome the adversities.

At Fortune Business Insights, we are striving to help your business sustain amid the pandemic by offering a comprehensive report that includes a detailed impact analysis on the market.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit:

Highlights of the Report:

This report incorporates an in-depth analysis of the overall growth prospects in the market. Furthermore, it provides insights into the comprehensive competitive landscape of the global market. A dashboard overview of leading companies, including their marketing strategies, market contribution, and recent developments is presented in both historic and present contexts.

Drivers & Restraints-

Rising Instances of Chronic Diseases Worldwide to Drive Growth

The increasing prevalence of chronic diseases across the world is expected to drive the growth of the global recombinant proteins market. For instance, as per a report published by the World Health Organization on chronic diseases and health promotion, chronic diseases are likely to account for 60% of the global burden of diseases. In addition, the rising demand for protein biologics is set to further strengthen growth. However, the challenges associated with the regulatory approvals are projected to limit growth.

Regional Analysis:

The global recombinant proteins market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe dominated the global recombinant proteins market in 2019, owing to the rise in R&D of the pharmaceutical & biotechnology industries. Additionally, growing consolidation between small and medium sized companies operating in recombinant proteins development is likely to surge the market growth in Asia Pacific. Moreover, increased sales of products in the use of R&D experiments is fostering the market growth in the Asia Pacific countries. Latin America and Middle East & Africa are projected to register a comparatively lower CAGR by the end of the forecast period.

Regional Insights-

Increasing R&D in Pharmaceutical and Biotechnology Spaces to Aid North America Dominate

North America is estimated to lead the global recombinant proteins market due to the increasing research and development activities in pharmaceutical and biotechnology spaces. For instance, according to a research by Select USA, Over 800,000 people work in the biopharmaceutical industry in the U.S., including a broad range of occupations such as scientific research, technical support, and manufacturing.

Competitive Landscape-

Investing in R&D to Help Key Players Develop Therapeutic Drugs

The global recombinant proteins market comprises various manufacturers and businesses focused on offering advanced solutions to gain a competitive edge. Prominent players are investing in R&D to identify new applications of recombinant proteins in order to develop therapeutic products for several diseases. This will help them expand their product portfolios.

Have Any Query? Ask Our Experts:

Industry Developments-

  • In June 2020, Lonza launched GSv9, a new media, to support the production of recombinant proteins using the company’s GS Gene expression system.
  • In March 2020, AMS Biotechnology launched recombinant proteins and antibodies for the detection of the COVID-19 virus. The company offers a wide range of products including assays, recombinant proteins, and cell lines, particularly for drug development.

A List of Key Manufacturers Operating In the Global Recombinant Proteins Market Report:

  • Sigma Aldrich Company Ltd.
  • Novoprotein Scientific
  • Thermo Fisher Scientific
  • Merck KGaA
  • Abcam PLC
  • Lonza
  • GenScript Biotech Corporation
  • ProSpec Tany TechnoGene, Ltd.
  • Others

What are the key segments in the market?

Global Recombinant Proteins Market Segmentation :

By Type

  • Hormones
  • Growth Factors
  • Antibody
  • Enzyme
  • Others

By Application

  • Therapeutic
  • Research

By End User

  • Biopharmaceutical Companies
  • Academic & research Institutes
  • Others

By Geography

  • North America (USA, Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and the Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)

    With tables and figures helping analyse worldwide Global recombinant proteins Market Forecast provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

More Trending Topics from Fortune Business Insights:

Patient Handling Equipment Market Set for Rapid Growth and Trend by 2021-2026 | Covid-19 Analysis

Orthopedic Power Tools Market Set for Rapid Growth and Trend by 2021-2026 | Covid-19 Analysis

Pyrogen Testing Market Set for Rapid Growth and Trend by 2021-2026 | Covid-19 Analysis

Home Rehabilitation Products Market Set for Rapid Growth and Trend by 2021-2026 | Covid-19 Analysis

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Fortune Business Insights™

LinkedIn | Twitter | Blogs


Related Reports :

Alzheimer’s Drugs Market

Alzheimer’s Drugs Market Size

Alzheimer’s Drugs Market Share

Alzheimer’s Drugs Market Trends

Alzheimer’s Drugs Market Growth

Alzheimer’s Drugs Market Analysis

Alzheimer’s Drugs Market Business Opportunities

Alzheimer’s Drugs Market Key Players

Alzheimer’s Drugs Market Demand

Alzheimer’s Drugs Market Competitive Landscape

Alzheimer’s Drugs Market Segments

Alzheimer’s Drugs Market Overview

Alzheimer’s Drugs Market Industry

Alzheimer’s Drugs Market Stastistic

Alzheimer’s Drugs Market Devlopment Strategy

Alzheimer’s Drugs Market Future Growth

Alzheimer’s Drugs Market Research Methodology

Alzheimer’s Drugs Market Drivers

Alzheimer’s Drugs Market Manufacturers

Alzheimer’s Drugs Market Revenue

Alzheimer’s Drugs Market Growth Analysis

Alzheimer’s Drugs Market Search Analysis

Alzheimer’s Drugs Market Condition

Alzheimer’s Drugs Market Covid Effect

Alzheimer’s Drugs Market CAGR Value


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *